During cerebral ischemia, elevation of TNF-α and glutamate to pathophysiological levels in the hippocampus may induce dysregulation of normal synaptic processes, leading ultimately to cell death. Previous studies have shown that patients subjected to a mild transient ischemic attack within a critical time window prior to a more severe ischemic episode may show attenuation in the clinical severity of the stroke and result in a more positive functional outcome. In this study we have investigated the individual contribution of pre-exposure to TNF-α or glutamate in the development of 'ischemic tolerance' to a subsequent insult, using organotypic hippocampal cultures. At 6 days in vitro (DIV), cultures were exposed to an acute concentration of glutamate (30 μM) or TNF-α (5 ng/ml) for 30 min, followed by 24 h recovery period. We then examined the effect of the pretreatments on calcium dynamics of the cells within the CA region. We found that pretreatment with TNF-α or glutamate caused in a significant reduction in subsequent glutamate-induced Ca 2+ influx 24 h later (control: 100.0 ± 0.8%, n = 7769 cells; TNF-α: 76.8 ± 1.0%, n = 5543 cells; glutamate: 75.3 ± 1.4%, n = 3859 cells; p < 0.001). Antagonism of circulating TNF-α (using infliximab, 25 μg/ml), and inhibition of the p38 MAP kinase pathway (using SB 203580, 10 μM) completely reversed this effect. However glutamate preconditioning did not appear to be mediated by p38 MAP kinase signalling, or NMDAR activation as neither SB 203580 nor D-AP5 (100 μM) altered this effect. Glutamate and TNF-α preconditioning resulted in small yet significant alterations in resting Ca 2+ levels (control: 100.0 ± 0.9%, n = 2994 cells; TNF-α: 109.7 ± 1.0%, n = 2884 cells; glutamate; 93.3 ± 0.8%, n = 2899 cells; p < 0.001), TNF-α's effect reversed by infliximab and SB 203580. Both TNF-α and glutamate also resulted in the reduction of the proportion (P) of responsive cells within the CA region of the hippocampus (control; P = 0.459, 0.451 ≤ x ≥ 0.467, n = 14,968 cells, TNF-α; P = 0.40, 0.392 ≤ x ≥ 0.407, n = 15,218; glutamate; P = 0.388, 0.303 ≤ x≥0.396, n = 13,919 cells), and in the depression of the frequency of spontaneous Ca 2+ events (vs. control: TNF-α: p > 0.00001, D = 0.0454; glutamate:
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Introduction
Physiological levels of glutamate and pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), play a key role in the regulation of synaptic plasticity within the hippocampus, the brain region involved in memory processing and consolidation (Malenka, 1994; Wittenberg and Tsien, 2002; Bliss and Collingridge, 1993; Albensi and Mattson, 2000; Pickering et al., 2005) . During a cerebral ischemic event such as a stroke, a vast array of adverse conditions ensue, including hypoxia, energy failure, cytotoxic edema, glutamateinduced excitotoxicity and inflammation, and ultimately neuronal dysfunction, which may, under severe conditions, lead to Ca 2+ dependent/independent cell death within the region of the insult (Dirnagl et al., 1999; Rosenberg, 1999; Barber et al., 2001) . Neuronal damage within the hippocampal region during a cerebral ischemic event may result in difficulties in the formation of new memories (anterograde amnesia) and the recollection of memories prior to neuronal injury (retrograde amnesia) (Zola-Morgan et al., 1986; Batchelor et al., 2008) . However the extent of neuronal injury and corresponding clinical manifestation may be reduced if the stroke patient experiences a mild transient ischemic attack (TIA) within a critical time window prior to this. This concept of 'ischemic tolerance' has been well documented in a clinical setting whereby stroke patients who have experienced a TIA prior to a more severe cerebral ischaemic event have an overall reduced infarct volume in the region of the insult and also result in a greater functional outcome, than those who did not experience a TIA (Castillo et al., 2003; Weih et al., 1999; Wegener et al., 2004; Moncayo et al., 2000) . This effect can also be seen in experimental models of stroke, both in vivo (Barone et al., 1998; Kitagawa et al., 1990; Matsushima and Hakim, 1995) and in vitro (Pringle et al., 1999; Liu et al., 2000) . Journal of Neuroimmunology 234 (2011) 27-39 
